Insight Molecular Diagnostics Advances GraftAssureDx FDA Review
NASHVILLE, Tennessee, August 10, 2026 Insight Molecular Diagnostics, Inc. (iMDx) reported second-quarter 2026 results and provided an update on...
kidney transplant
Advertisement
LifeMine Raises $263M to Advance LIFE-001 Transplant Therapy
WATERTOWN, Mass., August 6, 2026 LifeMine Therapeutics has secured $263 million in financing to accelerate the clinical development of...
Ipsen Acquires Memo Therapeutics to Expand Rare Disease Pipeline
PARIS, France & SCHLIEREN/ZURICH, Switzerland, July 1, 2026 Ipsen has announced a definitive agreement to acquire Memo Therapeutics AG,...
Verici Dx Achieves Nationwide Access Following New York State Approval
FRANKLIN, Tenn., June 24, 2026 Verici Dx plc announced that it has received clinical laboratory accreditation from the New...
CareDx Publishes New KOAR Kidney Transplant Data
BRISBANE, Calif. | June 16, 2026 CareDx, Inc. has announced the publication of the second analysis from the Kidney...
Advertisements
IMDx GraftAssure Assay Demonstrates Superior Accuracy for Kidney Transplant Rejection Monitoring
NASHVILLE, Tenn., June 11, 2026 Insight Molecular Diagnostics, Inc. (Nasdaq: IMDX) announced that the American Journal of Transplantation has...
Memo Therapeutics Phase II Potravitug Shows Strong BKPyV Clearance
SCHLIEREN / ZURICH, Switzerland, June 5, 2026 Memo Therapeutics AG announced additional positive analyses from its Phase II SAFE...
Synklino Doses First Patient in Phase 1 SYN002 CMV Trial
COPENHAGEN, Denmark — May 28, 2026 Synklino A/S announced that the first patient has been dosed in a first-in-human...
AstraZeneca and Daiichi Sankyo Secure FDA Approval for Enhertu in Early HER2 Breast Cancer
WILMINGTON, Del., May 15, 2026 AstraZeneca and Daiichi Sankyo have announced that the U.S. Food and Drug Administration (FDA)...
SERB and Hansa Biopharma Strengthen Rare Disease Portfolio With Idefirix Agreement
BRUSSELS, Belgium, May 19, 2026 SERB Pharmaceuticals and Hansa Biopharma have announced a strategic €115 million licensing agreement granting...
Advertisement
